Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial

Autor: Gluz, O. *, Liedtke, C., Huober, J., Peyro-Saint-Paul, H., Kates, R.E., Kreipe, H.H., Hartmann, A., Pelz, E., Erber, R., Mohrmann, S., Möbus, V., Augustin, D., Hoffmann, G., Thomssen, C., Jänicke, F., Kiechle, M., Wallwiener, D., Kuhn, W., Nitz, U., Harbeck, N.
Zdroj: In Annals of Oncology June 2016 27(6):1035-1040
Databáze: ScienceDirect